Cerebrovascular disorders in patients with type 2 diabetes mellitus and resistant hypertension

Cerebrovascular disorders in patients with type 2 diabetes mellitus and resistant hypertension

BACKGROUND: Diabetes mellitus (DM) and hypertension are risk factors for cerebral stroke, which are exacerbated by the combination of these diseases. Identifying the factors involved in the development of subclinical brain damage could change the therapeutic strategy for protecting the brain.AIM: to...

Full description

Bibliographic Details
Main Authors:	A. Yu. Falkovskaya, V. F. Mordovin, A. E. Sukhareva, I. V. Zyubanova, M. A. Manukyan, V. A. Lichikaki, E. I. Tsoi, A. M. Gusakova, N. V. Dorozhkina
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2022-05-01
Series:	Сахарный диабет
Subjects:	diabetes mellitus resistant hypertension brain mri cerebrovascular disease, cytokines, adipokines, vasoreactivity
Online Access:	https://www.dia-endojournals.ru/jour/article/view/12779

Similar Items

Long-term outcomes of renal denervation and related sex characteristics: data from a three-year follow-up
by: I. V. Zyubanova, et al.
Published: (2021-05-01)

Refractory and resistant hypertension in patients with type 2 diabetes mellitus: differences in metabolic profile and endothelial function
by: Alla Y. Falkovskaya, et al.
Published: (2021-01-01)

Early cerebrovascular and long-term neurological modifications ensue following juvenile mild traumatic brain injury in male mice
by: Aleksandra Ichkova, et al.
Published: (2020-07-01)

"Grey zone" of vasoreactivity during acute vasodilator testing in patients with pulmonary hypertension
by: O V Sagaydak, et al.
Published: (2016-06-01)

Cerebrovascular reactivity in patients with rheumatoid arthritis concurrent with and without hypertension
by: N V Rebrova, et al.
Published: (2015-04-01)

Frequency of acute vasodilator response (AVR) in incident and prevalent patients with pulmonary arterial hypertension: Results from the pulmonary vascular disease phenomics study
by: Mario Naranjo, et al.
Published: (2023-07-01)

Features of heart failure with preserved ejection fraction (HFpEF) in diabetic patients with resistant hypertension
by: M. A. Manukyan, et al.
Published: (2021-11-01)

Type 1 neurofibromatosis complicated by pulmonary arterial hypertension: a case report
by: Murathan Küçük, et al.
Published: (2017-07-01)

Clinical and pathogenetic aspects of hypertensive crises in patients with early signs of chronic cerebrovascular diseases
by: Yu. Ya. Varakin, et al.
Published: (2017-02-01)

On the possibility to increase sensitivity of diagnostic tests for fixed pulmonary hypertension in heart transplant candidates
by: M. A. Bortsova, et al.
Published: (2019-07-01)

TRANSCRANIAL MAGNETOTHERAPY IN THE REHABILITATION OF PATIENTS WITH ARTERIAL HYPERTENSION COMBINED WITH CHRONIC CEREBROVASCULAR PATHOLOGY
by: E. V. Sevostyanova, et al.
Published: (2019-02-01)

Hypertensive crisis as cerebrovascular disease risk factor
by: M A Kravchenko, et al.
Published: (2018-06-01)

Cerebrovascular reactivity depending on rheumatoid factor and anticitrullinated protein antibody positivity in hypertensive patients with rheumatoid arthritis
by: N. V. Rebrova, et al.
Published: (2022-07-01)

Growing up with Idiopathic Pulmonary Arterial Hypertension: An Arduous Journey
by: Tanguy Dutilleux, et al.
Published: (2023-05-01)

Human cerebrovascular function in health and disease: insights from integrative approaches
by: Erin D. Ozturk, et al.
Published: (2018-02-01)

Altered Cerebral Vasoreactivity on Transcranial Color-Coded Sonography Related to Akinetic-Rigid Phenotype of Parkinson’s Disease: Interim Analysis of a Cross-Sectional Study
by: Rodrigo Tavares Brisson, et al.
Published: (2023-04-01)

Editorial: Calcium and pulmonary hypertension
by: Ji-Feng Li, et al.
Published: (2022-11-01)

Self-reported physician practices in pulmonary arterial hypertension: Diagnosis, assessment, and referral
by: Susan Polanco-Briceno, et al.
Published: (2016-04-01)

Vasoreactive Pulmonary Arterial Hypertension Manifesting With Misleading Epileptic Seizure: Diagnostic and Treatment Pitfalls
by: Nesrine Farhat, et al.
Published: (2019-07-01)

COMPORTAMIENTO DE LA MORTALIDAD POR ENFERMEDAD CEREBROVASCULAR EN PACIENTES HIPERTENSOS Lethality behavior of cerebrovascular diseases in hypertensive patients
by: Heydi Flores Podadera, et al.
Published: (2008-06-01)

Endothelial vasomotor function and global arterial distensibility in ischaemic cerebrovascular diseases and arterial hypertension
by: L. A. Geraskina, et al.
Published: (2017-02-01)

Association Between Risk of Obstructive Sleep Apnea and Cerebrovascular Reactivity in Stroke Patients
by: Renan C. Castello‐Branco, et al.
Published: (2020-03-01)

ROLE OF PERIVASCULAR ADIPOSE TISSUE IN THE DEVELOPMENT OF ATHEROSCLEROTIC AND NONATHEROSCLEROTIC DISEASES
by: E. G. Uchasova, et al.
Published: (2019-10-01)

Hypertension, BMI, and cardiovascular and cerebrovascular diseases
by: Qiao Wenjing, et al.
Published: (2021-01-01)

The antioxidant defense system at early stages of chronic cerebrovascular pathology
by: E. V. Gnedovskaya, et al.
Published: (2017-02-01)

Acute vasoreactivity testing during right heart catheterization in chronic thromboembolic pulmonary hypertension: Results from the pulmonary vascular disease phenomics study
by: Robert P. Frantz, et al.
Published: (2023-01-01)

Favorable effect of renal denervation on elevated renal vascular resistance in patients with resistant hypertension and type 2 diabetes mellitus
by: Musheg Manukyan, et al.
Published: (2022-12-01)

Criteria for selecting patients with resistant hypertension for a renal sympathetic denervation
by: T M Ripp, et al.
Published: (2016-08-01)

Physiological systemic and cerebrovascular determinants of the risk of stroke, chronic cerebral ischaemia and vascular cognitive impairment
by: Webb, A
Published: (2021)

Diagnostic value of physical examination for topographic detection of infratentorial lesions in patients with cerebrovascular syndromes
by: Ghandehari K, et al.
Published: (2014-05-01)

Comparison of Near-Infrared Spectroscopy-Based Cerebral Autoregulatory Indices in Extremely Low Birth Weight Infants
by: Howard Chao, et al.
Published: (2023-08-01)

Age-, Gender-, and in Vivo Different Doses of Isoproterenol Modify in Vitro Aortic Vasoreactivity and Circulating VCAM-1
by: Betzabé Nieto-Lima, et al.
Published: (2018-01-01)

Factores de riesgo de la enfermedad cerebrovascular aguda hipertensiva Risk factors of hypertensive acute cerebrovascular disease (HACVD)
by: Alexis Álvarez-Aliaga, et al.
Published: (2006-12-01)

MRI of the arterial wall in resistant hypertension associated with type 2 diabetes mellitus
by: Nadezhda I. Ryumshina, et al.
Published: (2020-04-01)

Factores de riesgos de la enfermedad cerebrovascular aguda Risk factors of hypertensive acute cerebrovascular disease
by: Adonis Frómeta Guerra, et al.
Published: (2010-11-01)

Endothelial Dysfunction Diagnostic “Platform” in patients with diabetes mellitus
by: I. A. Khripun, et al.
Published: (2022-03-01)

Adherence to treatment in patients with cerebrovascular disease as a multifactorial problem
by: M. M. Tanashyan, et al.
Published: (2023-02-01)

Parameters of acute vasoreactivity testing after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension
by: Sergey Y. Yarovoy, et al.
Published: (2020-10-01)

INFLUENCE OF 24-HOUR BLOOD PRESSURE PATTERNS ON STRUCTURAL AND FUNCTIONAL CHANGES OF THE HEART IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION
by: V. A. Lichikaki, et al.
Published: (2015-04-01)

The structure of cerebrovascular diseases in an open population of Ulyanovsk
by: L. A. Belova, et al.
Published: (2017-02-01)